You are here

Tenecteplase: Innovative Fibrinolysis for ST-Segment Elevation Myocardial Infarction (STEMI)

Gordon J. Vanscoy, PharmD, CACP, MBA, Thomas L. Rihn, PharmD, and Pamela H. Koerner, PharmD
PDF version: 
When combined with potent antiplatelet agents and low-molecular-weight heparins, tenecteplase has demonstrated improved patient outcomes.